RSV

The U.S. is experiencing an unusual spate of childhood RSV infections. But the critical shortage of beds to treat ailing children stems from structural problems in pediatric care that have been brewing for years.

Elena Cyrus, a University of Central Florida epidemiologist, says Florida’s sprawling demographic of children and seniors puts it at risk of seeing dangerous increases of COVID, RSV and flu.

On this episode of "What's Health Got to Do With It," a panel examines the biggest health care headlines with its monthly medical roundtable.

Makers of products like Children's Tylenol say they're trying to keep up with big demand as RSV, flu and COVID spread. But medical experts note that kids' fevers don't always call for medicine.

As the holiday approaches, infectious disease specialists are bracing for the possibility that big family get-togethers and travel will propel the spread of RSV, flu and COVID.

Doctors say a higher-than-normal amount of respiratory syncytial virus cases — which primarily affect children — are keeping them busy. But they say things are under control.

Doctors say they are seeing an unprecedented number of cases. How concerned should parents be? Why are young children so vulnerable? What's causing this year's outbreak? We offer some answers.

Pfizer reported preliminary results of its pregnancy vaccine, a shot it also tested successfully in older adults. Rival GSK also has reported success with its vaccine version in seniors.

The hospital is “definitely in an RSV outbreak situation,” with more than 10% of patients testing positive for the illness.

The medical director at Accel Research Sites in DeLand expects a shot for RSV to be available by the new year and a combination RSV, COVID and flu shot by next fall.